title: Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses.
authors: VISN-22 Mental Illness Research, Education & Clinical Center (MIRECC), VA San Diego Healthcare System, CA 92161, USA and Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
authors: Veronica B
authors: VB
authors: Perez
authors: Neal R
authors: NR
authors: Swerdlow
authors: David L
authors: DL
authors: Braff
authors: Risto
authors: R
authors: Näätänen
authors: Gregory A
authors: GA
authors: Light
mesh_terms: D000465:Algorithms; D014150:Antipsychotic Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000378:metabolism*; D006801:Humans; D011618:Psychotic Disorders / Q000175:diagnosis* / Q000188:drug therapy; D012307:Risk Factors
chemical_list: D014150:Antipsychotic Agents; D015415:Biomarkers